MCP-1/CCL2 knockout was demonstrated to inhibit the development of albuminuria and to reduce the number of atrophic tubules promptly after diabetes onset in streptozotocin-induced diabetic mice [46,50]. The gene discussed is CCL2; the disease is diabetes mellitus.